ArticlePharmaceutical biology2023
Isoalantolactone suppresses gallbladder cancer progression via inhibiting the ERK signalling pathway.
Xingyu Lv et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it